The hospital said the new centre will improve access to specialised interventions such as Deep Brain Stimulation
Through the partnership, she plans to share her experience—from consultation through recovery—across her social media platforms
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
Collaboration aims to align hospital staff learning with NABH 6th Edition standards, patient safety, and measurable quality outcomes
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
Funding to accelerate growth of concierge-style private health services and Aayu’s paperless hospital infrastructure platform
The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations
The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck
New Yamuna Vihar facility to train 40 students annually through diploma-led, hands-on renal care education
Subscribe To Our Newsletter & Stay Updated
